<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <meta name="generator" content="pandoc">
  <meta name="author" content="Adam La Caze" />
  <title>Cases in research ethics</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="files/reveal.js-3.3.0.1/css/reveal.css"/>



<link rel="stylesheet" href="files/reveal.js-3.3.0.1/css/theme/white.css" id="theme">


  <!-- some tweaks to reveal css -->
  <style type="text/css">
    .reveal h1 { font-size: 2.0em; }
    .reveal h2 { font-size: 1.5em;  }
    .reveal h3 { font-size: 1.25em;	}
    .reveal h4 { font-size: 1em;	}

    .reveal .slides>section,
    .reveal .slides>section>section {
      padding: 0px 0px;
    }



    .reveal table {
      border-width: 1px;
      border-spacing: 2px;
      border-style: dotted;
      border-color: gray;
      border-collapse: collapse;
      font-size: 0.7em;
    }

    .reveal table th {
      border-width: 1px;
      padding-left: 10px;
      padding-right: 25px;
      font-weight: bold;
      border-style: dotted;
      border-color: gray;
    }

    .reveal table td {
      border-width: 1px;
      padding-left: 10px;
      padding-right: 25px;
      border-style: dotted;
      border-color: gray;
    }


  </style>

    <style type="text/css">code{white-space: pre;}</style>

    <link rel="stylesheet" href="files/myreveal.css"/>

<!-- Printing and PDF exports -->
<script id="paper-css" type="application/dynamic-css">

/* Default Print Stylesheet Template
   by Rob Glazebrook of CSSnewbie.com
   Last Updated: June 4, 2008

   Feel free (nay, compelled) to edit, append, and
   manipulate this file as you see fit. */


@media print {

	/* SECTION 1: Set default width, margin, float, and
	   background. This prevents elements from extending
	   beyond the edge of the printed page, and prevents
	   unnecessary background images from printing */
	html {
		background: #fff;
		width: auto;
		height: auto;
		overflow: visible;
	}
	body {
		background: #fff;
		font-size: 20pt;
		width: auto;
		height: auto;
		border: 0;
		margin: 0 5%;
		padding: 0;
		overflow: visible;
		float: none !important;
	}

	/* SECTION 2: Remove any elements not needed in print.
	   This would include navigation, ads, sidebars, etc. */
	.nestedarrow,
	.controls,
	.fork-reveal,
	.share-reveal,
	.state-background,
	.reveal .progress,
	.reveal .backgrounds {
		display: none !important;
	}

	/* SECTION 3: Set body font face, size, and color.
	   Consider using a serif font for readability. */
	body, p, td, li, div {
		font-size: 20pt!important;
		font-family: Georgia, "Times New Roman", Times, serif !important;
		color: #000;
	}

	/* SECTION 4: Set heading font face, sizes, and color.
	   Differentiate your headings from your body text.
	   Perhaps use a large sans-serif for distinction. */
	h1,h2,h3,h4,h5,h6 {
		color: #000!important;
		height: auto;
		line-height: normal;
		font-family: Georgia, "Times New Roman", Times, serif !important;
		text-shadow: 0 0 0 #000 !important;
		text-align: left;
		letter-spacing: normal;
	}
	/* Need to reduce the size of the fonts for printing */
	h1 { font-size: 28pt !important;  }
	h2 { font-size: 24pt !important; }
	h3 { font-size: 22pt !important; }
	h4 { font-size: 22pt !important; font-variant: small-caps; }
	h5 { font-size: 21pt !important; }
	h6 { font-size: 20pt !important; font-style: italic; }

	/* SECTION 5: Make hyperlinks more usable.
	   Ensure links are underlined, and consider appending
	   the URL to the end of the link for usability. */
	a:link,
	a:visited {
		color: #000 !important;
		font-weight: bold;
		text-decoration: underline;
	}
	/*
	.reveal a:link:after,
	.reveal a:visited:after {
		content: " (" attr(href) ") ";
		color: #222 !important;
		font-size: 90%;
	}
	*/


	/* SECTION 6: more reveal.js specific additions by @skypanther */
	ul, ol, div, p {
		visibility: visible;
		position: static;
		width: auto;
		height: auto;
		display: block;
		overflow: visible;
		margin: 0;
		text-align: left !important;
	}
	.reveal pre,
	.reveal table {
		margin-left: 0;
		margin-right: 0;
	}
	.reveal pre code {
		padding: 20px;
		border: 1px solid #ddd;
	}
	.reveal blockquote {
		margin: 20px 0;
	}
	.reveal .slides {
		position: static !important;
		width: auto !important;
		height: auto !important;

		left: 0 !important;
		top: 0 !important;
		margin-left: 0 !important;
		margin-top: 0 !important;
		padding: 0 !important;
		zoom: 1 !important;

		overflow: visible !important;
		display: block !important;

		text-align: left !important;
		-webkit-perspective: none;
		   -moz-perspective: none;
		    -ms-perspective: none;
		        perspective: none;

		-webkit-perspective-origin: 50% 50%;
		   -moz-perspective-origin: 50% 50%;
		    -ms-perspective-origin: 50% 50%;
		        perspective-origin: 50% 50%;
	}
	.reveal .slides section {
		visibility: visible !important;
		position: static !important;
		width: auto !important;
		height: auto !important;
		display: block !important;
		overflow: visible !important;

		left: 0 !important;
		top: 0 !important;
		margin-left: 0 !important;
		margin-top: 0 !important;
		padding: 60px 20px !important;
		z-index: auto !important;

		opacity: 1 !important;

		page-break-after: always !important;

		-webkit-transform-style: flat !important;
		   -moz-transform-style: flat !important;
		    -ms-transform-style: flat !important;
		        transform-style: flat !important;

		-webkit-transform: none !important;
		   -moz-transform: none !important;
		    -ms-transform: none !important;
		        transform: none !important;

		-webkit-transition: none !important;
		   -moz-transition: none !important;
		    -ms-transition: none !important;
		        transition: none !important;
	}
	.reveal .slides section.stack {
		padding: 0 !important;
	}
	.reveal section:last-of-type {
		page-break-after: avoid !important;
	}
	.reveal section .fragment {
		opacity: 1 !important;
		visibility: visible !important;

		-webkit-transform: none !important;
		   -moz-transform: none !important;
		    -ms-transform: none !important;
		        transform: none !important;
	}
	.reveal section img {
		display: block;
		margin: 15px 0px;
		background: rgba(255,255,255,1);
		border: 1px solid #666;
		box-shadow: none;
	}

	.reveal section small {
		font-size: 0.8em;
	}

}  
</script>


<script id="pdf-css" type="application/dynamic-css">
    
/**
 * This stylesheet is used to print reveal.js
 * presentations to PDF.
 *
 * https://github.com/hakimel/reveal.js#pdf-export
 */

* {
	-webkit-print-color-adjust: exact;
}

body {
	margin: 0 auto !important;
	border: 0;
	padding: 0;
	float: none !important;
	overflow: visible;
}

html {
	width: 100%;
	height: 100%;
	overflow: visible;
}

/* Remove any elements not needed in print. */
.nestedarrow,
.reveal .controls,
.reveal .progress,
.reveal .playback,
.reveal.overview,
.fork-reveal,
.share-reveal,
.state-background {
	display: none !important;
}

h1, h2, h3, h4, h5, h6 {
	text-shadow: 0 0 0 #000 !important;
}

.reveal pre code {
	overflow: hidden !important;
	font-family: Courier, 'Courier New', monospace !important;
}

ul, ol, div, p {
	visibility: visible;
	position: static;
	width: auto;
	height: auto;
	display: block;
	overflow: visible;
	margin: auto;
}
.reveal {
	width: auto !important;
	height: auto !important;
	overflow: hidden !important;
}
.reveal .slides {
	position: static;
	width: 100%;
	height: auto;

	left: auto;
	top: auto;
	margin: 0 !important;
	padding: 0 !important;

	overflow: visible;
	display: block;

	-webkit-perspective: none;
	   -moz-perspective: none;
	    -ms-perspective: none;
	        perspective: none;

	-webkit-perspective-origin: 50% 50%; /* there isn't a none/auto value but 50-50 is the default */
	   -moz-perspective-origin: 50% 50%;
	    -ms-perspective-origin: 50% 50%;
	        perspective-origin: 50% 50%;
}

.reveal .slides section {
	page-break-after: always !important;

	visibility: visible !important;
	position: relative !important;
	display: block !important;
	position: relative !important;

	margin: 0 !important;
	padding: 0 !important;
	box-sizing: border-box !important;
	min-height: 1px;

	opacity: 1 !important;

	-webkit-transform-style: flat !important;
	   -moz-transform-style: flat !important;
	    -ms-transform-style: flat !important;
	        transform-style: flat !important;

	-webkit-transform: none !important;
	   -moz-transform: none !important;
	    -ms-transform: none !important;
	        transform: none !important;
}

.reveal section.stack {
	margin: 0 !important;
	padding: 0 !important;
	page-break-after: avoid !important;
	height: auto !important;
	min-height: auto !important;
}

.reveal img {
	box-shadow: none;
}

.reveal .roll {
	overflow: visible;
	line-height: 1em;
}

/* Slide backgrounds are placed inside of their slide when exporting to PDF */
.reveal section .slide-background {
	display: block !important;
	position: absolute;
	top: 0;
	left: 0;
	width: 100%;
	z-index: -1;
}

/* All elements should be above the slide-background */
.reveal section>* {
	position: relative;
	z-index: 1;
}

/* Display slide speaker notes when 'showNotes' is enabled */
.reveal .speaker-notes-pdf {
	display: block;
	width: 100%;
	max-height: none;
	left: auto;
	top: auto;
	z-index: 100;
}

/* Display slide numbers when 'slideNumber' is enabled */
.reveal .slide-number-pdf {
	display: block;
	position: absolute;
	font-size: 14px;
}

</script>


<script>
var style = document.createElement( 'style' );
style.type = 'text/css';
var style_script_id = window.location.search.match( /print-pdf/gi ) ? 'pdf-css' : 'paper-css';
var style_script = document.getElementById(style_script_id).text;
style.innerHTML = style_script;
document.getElementsByTagName('head')[0].appendChild(style);
</script>

</head>
<body>
  <div class="reveal">
    <div class="slides">

<section>
    <h1 class="title">Cases in research ethics</h1>
    <h2 class="author">Adam La Caze</h2>
    <h3 class="date">August 2019</h3>
</section>

<section id="objectives" class="slide level2">
<h2>Objectives</h2>
<ol type="1">
<li>Apply the knowledge you have developed regarding human research ethics</li>
<li>Further develop your understanding of research ethics through the discussion of a number of contentious cases</li>
<li>Further develop your ethical reasoning skills</li>
</ol>
</section>
<section id="principles-of-research-ethics" class="slide level2">
<h2>Principles of research ethics</h2>
<ul>
<li>Research merit and integrity</li>
<li>Respect autonomy</li>
<li>Promote good outcomes (beneficence)</li>
<li>Avoid harm (non-maleficence)</li>
<li>Be fair (justice)</li>
</ul>
</section>
<section id="national-statement-elements-of-research" class="slide level2">
<h2>National Statement: Elements of Research</h2>
<ol type="1">
<li>Research scope, aims, themes, questions and methods</li>
<li>Recruitment</li>
<li>Consent</li>
<li>Collection, use and management of data and information</li>
<li>Communication of research findings or results to participants</li>
<li>Dissemination of research outputs and outcomes</li>
<li>After the project</li>
</ol>
<p class="question">
Read this section of the <a href="https://www.nhmrc.gov.au/about-us/publications/national-statement-ethical-conduct-human-research-2007-updated-2018#toc__374">National Statement</a>
</p>
</section>
<section id="phase-i-first-in-humans-trial" class="slide level2" data-background="#51247A">
<h2>Phase I, first-in-humans trial</h2>
<p><em>Anothernib</em> is a new biologic drug is being trialled in chronic myeloid leukaemia.</p>
<p>The objectives of the trial are to determine the maximum tolerated dose and, hopefully, gain some data on the minimal effective dose.</p>
<p>The trial will enrol patients that have failed all other treatments and have poor prognosis (life expectancy measured in months).</p>
<p class="questionalt fragment">
Discuss the key ethical considerations involved in such a study
</p>
<aside class="notes">
<p>There are a lot of examples of trials like this. For one example, see <span class="citation" data-cites="Druker:2001tx">Druker et al. (2001)</span>.</p>
</aside>
</section>
<section id="key-considerations" class="slide level2" data-background="#00A2C7">
<h2>Key considerations</h2>
<ul>
<li>Possibility of patient benefit is very small</li>
<li>How do we ensure that patients make an informed decision to participate?</li>
<li>Participants need a clear understanding of:
<ul>
<li>Likely benefit</li>
<li>Alternatives</li>
<li>The burdens of participation</li>
</ul></li>
</ul>
</section>
<section id="genetic-testing" class="slide level2" data-background="#fbb800">
<h2>Genetic testing</h2>
<p>A study seeks to assess a new drug for the treatment of skin cancer.</p>
<p>To participate in the trial, patients need to consent to genetic testing, including:</p>
<ul>
<li class="fragment">Testing for somatic mutations related to the tumour</li>
<li class="fragment">Pharmacogenomic mutations related to the pharmacokinetics of the investigational drug</li>
<li class="fragment">Genetic screening (including whole genome sequencing) for genes related to skin cancer</li>
</ul>
</section>
<section id="questions" class="slide level2">
<h2>Questions</h2>
<ul>
<li>Should genetic testing be the price of entry into a study?</li>
<li>What details regarding genetic testing need to be given to a participant so that they can make an informed decision?</li>
<li>In what situations should investigators communicate the results of genetic testing to participants?</li>
</ul>
<aside class="notes">
<p>This is a changing area.</p>
<p>See <a href="https://www.nhmrc.gov.au/about-us/publications/national-statement-ethical-conduct-human-research-2007-updated-2018#toc__826">National Statement</a> for discussion.</p>
<p><span class="citation" data-cites="Fabsitz2011">Fabsitz et al. (2011)</span> also provides discussion.</p>
</aside>
</section>
<section id="databank" class="slide level2">
<h2>Databank</h2>
<p>A pharmaceutical company that makes a new drug used for a rare genetic spinal disease seeks to set up a databank.</p>
<p>The databank will recruit all patients taking the drug and collect information on their response, other drugs, and related outcomes.</p>
<p>The company also seeks to collect any left over blood or tissue for genetic tests.</p>
<p>All data will be retained by the company and will not be accessible to third parties.</p>
<p class="question fragment">
Discuss the pros and cons of this proposal
</p>
</section>
<section id="considerations" class="slide level2">
<h2>Considerations</h2>
<p class="question">
This is a good example in which it is important to achieve two things: transparency and security (NS 3.1.55–62)
</p>
<p class="fragment">
Need to ensure that individual data cannot be re-identified
</p>
<p class="fragment">
Need to ensure that the data provided by participants is available for use by the scientific community (for the benefit of patients)
</p>
<aside class="notes">
<p>There is a lot of information available about Open Science and the risks of identifying participants from data sharing.</p>
<p>Two examples include: <a href="https://www.bmj.com/open-data">BMJ Open Data</a> and the <a href="https://www.oaic.gov.au/privacy/privacy-decisions/investigation-reports/mbspbs-data-publication/">Office of the Australian Information Commissioner</a> on the re-identification of PBS data shared publicly.</p>
</aside>
</section>
<section id="who-benefits" class="slide level2">
<h2>Who benefits?</h2>
<p class="question">
How should we assess a well-designed trial that is unlikely to benefit anyone other than the sponsor?
</p>
<ul>
<li class="fragment">Some me-too drugs provide limited public and individual patient benefit</li>
<li class="fragment">Esomeprazole is the <em>active</em> S-enantiomer of omeprazole (esomeprazole 20mg is roughly equivalent to omeprazole 40mg)</li>
<li class="fragment">Most trials compare esomeprazole 40mg with omeprazole 20mg or 40mg</li>
</ul>
</section>
<section id="industry-bias" class="slide level2">
<h2>Industry bias</h2>
<ul>
<li><span class="citation" data-cites="Lundh2017">Lundh et al. (2017)</span> conducted a meta-analysis of reports of studies that assessed samples of papers for industry bias</li>
<li>Industry sponsored studies more often had favourable efficacy results (RR 1.27, 95% CI 1.17–1.37)</li>
<li>This effect is present despite industry sponsored studies possessing similar (or lower) risk of bias when compared to non-industry sponsored studies.</li>
</ul>
<aside class="notes">
<p>For most of the studies included in the review ‘favourable efficacy results’ equated to statistical significance.</p>
<p>Some possible explanations for industry bias <span class="citation" data-cites="Lundh2017">(Lundh et al. 2017, 19)</span>:</p>
<ul>
<li>Inferior comparators</li>
<li>More likely to use placebo control</li>
<li>Active comparators at inferior doses</li>
<li>Inappropriate administration of drugs (?)</li>
<li>Choice of less-clinically relevant primary outcomes</li>
<li>Event coding, selective reporting and publication</li>
</ul>
</aside>
</section>
<section id="small" class="slide level2 unnumbered">
<h2>References</h2>
<div id="refs" class="references">
<div id="ref-Druker:2001tx">
<p>Druker, B J, M Talpaz, D J Resta, and Et Al. 2001. “Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.” <em>The New England Journal of Medicine</em> 344 (14): 1031–7.</p>
</div>
<div id="ref-Fabsitz2011">
<p>Fabsitz, Richard R, Amy Mcguire, Richard R Sharp, Mona Puggal, Laura M Beskow, Leslie G Biesecker, Ebony Bookman, et al. 2011. “Ethical and practical guidlines for reporting genetic research results to study participants: updated guidelines from an NHLBI working group.” <em>Circulation: Cardiovascular Genetics</em> 3 (6): 574–80. doi:<a href="https://doi.org/10.1161/CIRCGENETICS.110.958827.Ethical">10.1161/CIRCGENETICS.110.958827.Ethical</a>.</p>
</div>
<div id="ref-Lundh2017">
<p>Lundh, A, J Lexchin, B Mintzes, Schroll Jb, and L Bero. 2017. “Industry sponsorship and research outcome (Review).” <em>Cochrane Database of Systematic Reviews</em>, no. 2. doi:<a href="https://doi.org/10.1002/14651858.MR000033.pub3.www.cochranelibrary.com">10.1002/14651858.MR000033.pub3.www.cochranelibrary.com</a>.</p>
</div>
</div>
</section>
    </div>
  </div>

  <script src="files/reveal.js-3.3.0.1/lib/js/head.min.js"></script>
  <script src="files/reveal.js-3.3.0.1/js/reveal.js"></script>

  <script>

      // Full list of configuration options available at:
      // https://github.com/hakimel/reveal.js#configuration
      Reveal.initialize({
        // Display the page number of the current slide
        slideNumber: true,
        // Push each slide change to the browser history
        history: true,
        // Vertical centering of slides
        center: false,
        // Transition style
        transition: 'none', // none/fade/slide/convex/concave/zoom
        // Transition style for full page slide backgrounds
        backgroundTransition: 'default', // none/fade/slide/convex/concave/zoom



        // Optional reveal.js plugins
        dependencies: [
        ]
      });
    </script>
  <!-- dynamically load mathjax for compatibility with self-contained -->
  <script>
    (function () {
      var script = document.createElement("script");
      script.type = "text/javascript";
      script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
      document.getElementsByTagName("head")[0].appendChild(script);
    })();
  </script>

<script>
  (function() {
    if (window.jQuery) {
      Reveal.addEventListener( 'slidechanged', function(event) {  
        window.jQuery(event.previousSlide).trigger('hidden');
        window.jQuery(event.currentSlide).trigger('shown');
      });
    }
  })();
</script>


  </body>
</html>
